Shacey Petrovic

President and CEO,
Insulet Corporation

Shacey Petrovic has served as president and chief executive officer of Insulet since January 1, 2019 and has served on the board of directors since September 2018. She also serves on the board of directors of Exact Sciences Corporation. Prior to becoming chief executive officer, she served as Insulet’s president and chief operating officer from October 2016 to December 31, 2018. From February 2016 to October 2016, she served as the executive vice president and president, Diabetes Products, and from February 2015 to February 2016, she served as the chief commercial officer. From 2013 to 2015, Petrovic served as president and chief executive officer of Clinical Innovations, LLC, a developer and manufacturer of medical devices and diagnostics for women’s health. From 2000 to 2013, she served in a number of key roles at Hologic, Inc. and Cytyc Corporation, which merged with Hologic in October 2007, including vice president and general manager of Hologic’s GYN Surgical Products division, as well as various sales and marketing leadership roles in the U.S. and Europe. Petrovic earned her Bachelor of Science degree in biology from the University of Wisconsin.